Kyle Steenland1, Felicia C Goldstein2, Allan Levey2, Whitney Wharton2. 1. Department of Environmental Health, Rollins School of Public Health, Emory University, and Emory Alzheimer's Disease Research Center, Atlanta, GA, USA. 2. Department of Neurology, Emory University School of Medicine, and Emory Alzheimer's Disease Research Center, Atlanta, GA, USA.
Abstract
BACKGROUND: Several studies have shown higher Alzheimer's disease (AD) incidence rates are in African-Americans (AAs) than Caucasians (CCs). If this finding is consistent across studies, it raises important etiologic questions regarding factors responsible for this discrepancy. It also affects the likely public health burden of AD in the US in the future, as the non-Caucasian population becomes the majority. OBJECTIVE: Estimate the AA/CC rate ratio for AD incidence across all available studies. METHODS: We conducted a meta-analysis of population-based studies for the rate ratio (RR) of AD incidence for AAs versus CCs, after identifying six relevant studies from the literature. We calculated an AA/CC rate ratio across all studies using inverse-variance weighting, and assessed inter-study heterogeneity. Using these incidence data, as well as data on survival after diagnosis, and on all-cause mortality, we also estimated the US prevalence of AD among AAs and CCs. RESULTS: There were six population-based studies with data comparing AD incidence between AAs and CCs, with an estimated 370 AA and 640 CC incident cases. The meta-analysis RR showed that the AD rate for AAs was 64% higher than for CCs (RR = 1.64 (95% CI 1.35-2.00)) 1.35-2.00)), with no evidence of heterogeneity. We estimated the current US AD prevalence for ages 65-90 to be 5.5% for CCs, and 8.6% for AAs (prevalence ratio 1.56). CONCLUSION: AAs have an increased risk of incident and prevalent AD compared to CCs for reasons which are unknown, but are hypothesized to reflect biological, psychological, and socioeconomic factors.
BACKGROUND: Several studies have shown higher Alzheimer's disease (AD) incidence rates are in African-Americans (AAs) than Caucasians (CCs). If this finding is consistent across studies, it raises important etiologic questions regarding factors responsible for this discrepancy. It also affects the likely public health burden of AD in the US in the future, as the non-Caucasian population becomes the majority. OBJECTIVE: Estimate the AA/CC rate ratio for AD incidence across all available studies. METHODS: We conducted a meta-analysis of population-based studies for the rate ratio (RR) of AD incidence for AAs versus CCs, after identifying six relevant studies from the literature. We calculated an AA/CC rate ratio across all studies using inverse-variance weighting, and assessed inter-study heterogeneity. Using these incidence data, as well as data on survival after diagnosis, and on all-cause mortality, we also estimated the US prevalence of AD among AAs and CCs. RESULTS: There were six population-based studies with data comparing AD incidence between AAs and CCs, with an estimated 370 AA and 640 CC incident cases. The meta-analysis RR showed that the AD rate for AAs was 64% higher than for CCs (RR = 1.64 (95% CI 1.35-2.00)) 1.35-2.00)), with no evidence of heterogeneity. We estimated the current US AD prevalence for ages 65-90 to be 5.5% for CCs, and 8.6% for AAs (prevalence ratio 1.56). CONCLUSION: AAs have an increased risk of incident and prevalent AD compared to CCs for reasons which are unknown, but are hypothesized to reflect biological, psychological, and socioeconomic factors.
Authors: Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace Journal: Ann Neurol Date: 2011-03-18 Impact factor: 10.422
Authors: L Jaime Fitten; Freddy Ortiz; Lynn Fairbanks; George Bartzokis; Po Lu; Eric Klein; Giovanni Coppola; John Ringman Journal: Int J Geriatr Psychiatry Date: 2014-01-29 Impact factor: 3.485
Authors: Breno S Diniz; Meryl A Butters; Steven M Albert; Mary Amanda Dew; Charles F Reynolds Journal: Br J Psychiatry Date: 2013-05 Impact factor: 9.319
Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272
Authors: C E Shaaban; H J Aizenstein; D R Jorgensen; R L MacCloud; N A Meckes; K I Erickson; N W Glynn; J Mettenburg; J Guralnik; A B Newman; T S Ibrahim; P J Laurienti; A N Vallejo; C Rosano Journal: AJNR Am J Neuroradiol Date: 2017-08-03 Impact factor: 3.825
Authors: Antonio C Bianco; Alexandra Dumitrescu; Balázs Gereben; Miriam O Ribeiro; Tatiana L Fonseca; Gustavo W Fernandes; Barbara M L C Bocco Journal: Endocr Rev Date: 2019-08-01 Impact factor: 19.871
Authors: Andrea Denny; Marissa Streitz; Kristin Stock; Joyce E Balls-Berry; Lisa L Barnes; Goldie S Byrd; Raina Croff; Sujuan Gao; Crystal M Glover; Hugh C Hendrie; William T Hu; Jennifer J Manly; Krista L Moulder; Susan Stark; Stephen B Thomas; Rachel Whitmer; Roger Wong; John C Morris; Jennifer H Lingler Journal: Alzheimers Dement Date: 2020-08-17 Impact factor: 21.566
Authors: Luiza K Axelrud; Marcos L Santoro; Daniel S Pine; Fernanda Talarico; Ary Gadelha; Gisele G Manfro; Pedro M Pan; Andrea Jackowski; Felipe Picon; Elisa Brietzke; Rodrigo Grassi-Oliveira; Rodrigo A Bressan; Eurípedes C Miguel; Luis A Rohde; Hakon Hakonarson; Zdenka Pausova; Sintia Belangero; Tomas Paus; Giovanni A Salum Journal: Am J Psychiatry Date: 2018-03-02 Impact factor: 18.112
Authors: Kumar B Rajan; Jennifer Weuve; Robert S Wilson; Lisa L Barnes; Elizabeth A McAninch; Denis A Evans Journal: Neurology Date: 2019-12-05 Impact factor: 9.910
Authors: Olga M Herren; Silas E Burris; Shellie-Anne Levy; Keri Kirk; Kanesha S Banks; Victor L Jones; Breanna Beard; Denee T Mwendwa; Clive O Callender; Alfonso L Campbell Journal: Ethn Dis Date: 2019-04-18 Impact factor: 1.847
Authors: Sukriti Nag; Lisa L Barnes; Lei Yu; Robert S Wilson; David A Bennett; Julie A Schneider Journal: Neurology Date: 2020-08-05 Impact factor: 9.910